​

Verona Pharma Ownership | Who Owns Verona Pharma?

OverviewForecastRevenueFinancialsChartTranscripts

Verona Pharma Ownership Summary

Verona Pharma is owned by 9.37% institutional investors, 5.80% insiders, and 84.83% retail investors. Frazier life sciences management is the largest institutional shareholder, holding 4.11% of VRNA shares. Eventide Gilead N is the top mutual fund, with 2.22% of its assets in Verona Pharma shares.

VRNA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockVerona Pharma9.37%5.80%84.83%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Frazier life sciences management3.31M4.11%$47.93M
Morgan stanley864.03K1.07%$12.49M
Perceptive advisors6.39M0.98%$296.85M
Nea management company5.58M0.86%$259.36M
Bank of america corp /de/611.02K0.76%$8.84M
Blackrock430.43K0.53%$6.22M
Eventide asset management3.13M0.48%$145.46M
Maverick capital3.13M0.48%$145.29M
Wellington management group llp3.03M0.46%$140.49M
Vivo capital2.28M0.35%$106.07M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Aisling capital management lp1.12M18.38%$51.80M
Caligan partners lp1.44M16.90%$66.73M
Nea management company5.58M14.64%$259.36M
Vivo capital2.28M11.88%$106.07M
Perceptive advisors6.39M8.18%$296.85M
Alerce investment management88.00K7.19%$4.09M
Ctf capital management, lp236.77K6.22%$11.00M
First turn management641.90K5.34%$29.81M
Nan fung group133.04K5.28%$6.18M
Silverarc capital management516.01K5.24%$23.96M

Top Buyers

HolderShares% AssetsChange
Wellington management group llp3.03M0.03%1.15M
Darwin global management810.45K3.56%810.45K
Point72 asset management711.01K0.07%711.01K
Eventide asset management3.13M2.65%706.28K
Janus henderson group1.67M0.04%624.37K

Top Sellers

HolderShares% AssetsChange
Ra capital management1.77M1.09%-3.24M
Orbimed advisors---2.86M
Carlyle group---2.46M
Deep track capital, lp850.00K1.47%-2.33M
Vivo capital2.28M11.88%-1.27M

New Positions

HolderShares% AssetsChangeValue
Darwin global management810.45K3.56%810.45K$37.64M
Point72 asset management711.01K0.07%711.01K$33.02M
Vestal point capital, lp495.00K1.36%495.00K$22.99M
Ctf capital management, lp236.77K6.22%236.77K$11.00M
Gw&k investment management232.35K0.09%232.35K$10.79M

Sold Out

HolderChange
Zurcher kantonalbank (zurich cantonalbank)-2.00
Naples money management-100.00
National bank of canada /fi/-150.00
Redwood wealth management group-410.00
Quarry lp-2.00K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202420123.31%61,094,145-9.72%90.14%10623.26%6122.00%
Sep 30, 202416121.97%67,432,1272.42%821.25%8519.72%4948.48%
Jun 30, 202413111.97%65,836,577-1.14%811.16%7018.64%3322.22%
Mar 31, 2024117-4.88%66,592,785-1.29%8475.18%59-4.84%27-6.90%
Dec 31, 202312313.89%67,465,9633.39%100.16%6234.78%29-6.45%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Eventide Gilead N1.89M2.22%472.89K
T. Rowe Price Health Sciences1.51M1.78%1.51M
Eventide Healthcare & Life Sciences I1.23M1.45%227.47K
Bellevue Healthcare Ord1.10M1.36%1.10M
Federated Hermes Kaufmann Small Cap Grow938.50K1.15%-51.50K
Federated Hermes Kaufmann Small Cap A938.50K1.15%-51.50K
Federated Hermes Kaufmann Growth862.50K1.05%-282.50K
Federated Hermes Kaufmann R862.50K1.05%-282.50K
Hood River Small-Cap Growth Instl838.91K1.03%45.26K
Putnam Small Cap Growth A712.40K0.84%37.20K

Recent Insider Transactions

DateNameRoleActivityValue
Mar 12, 2025Rickard Kathleen A. Chief Medical OfficerSell$661.94K
Dec 04, 2024ZACCARDELLI DAVID President and CEOSell$338.16K
Dec 05, 2024ZACCARDELLI DAVID President and CEOSell$3.21M
Dec 06, 2024ZACCARDELLI DAVID President and CEOSell$815.40K
Dec 04, 2024Hahn Mark W Chief Financial OfficerSell$291.00K

Insider Transactions Trends

DateBuySell
2025 Q1-1
2024 Q4333
2024 Q318
2024 Q2-1
2024 Q1-1

VRNA Ownership FAQ

Who Owns Verona Pharma?

Verona Pharma shareholders are primarily institutional investors at 9.37%, followed by 5.80% insiders and 84.83% retail investors. The average institutional ownership in Verona Pharma's industry, Biotech Stocks , is 68.48%, which Verona Pharma falls below.

Who owns the most shares of Verona Pharma?

Verona Pharma’s largest shareholders are Frazier life sciences management (3.31M shares, 4.11%), Morgan stanley (864.03K shares, 1.07%), and Perceptive advisors (6.39M shares, 0.98%). Together, they hold 6.16% of Verona Pharma’s total shares outstanding.

Does Blackrock own Verona Pharma?

Yes, BlackRock owns 0.53% of Verona Pharma, totaling 430.43K shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 6.22M$. In the last quarter, BlackRock increased its holdings by 48.71K shares, a 12.76% change.

Who is Verona Pharma’s biggest shareholder by percentage of total assets invested?

Aisling capital management lp is Verona Pharma’s biggest shareholder by percentage of total assets invested, with 18.38% of its assets in 1.12M Verona Pharma shares, valued at 51.8M$.

Who is the top mutual fund holder of Verona Pharma shares?

Eventide Gilead N is the top mutual fund holder of Verona Pharma shares, with 2.22% of its total shares outstanding invested in 1.89M Verona Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools